INTRODUCTION: Carbapenemase-producing organisms (CPOs) are a growing threat to human health. Among the enzymes conferring antibiotic resistance produced by these organisms, Klebsiella pneumoniae carbapenemase (KPC) is considered to be a growing global health threat. Reliable and specific detection of this antibiotic resistance-causing enzyme is critical both for effective therapy and to mitigate further spread. OBJECTIVES: The objective of this study is to develop an intact protein mass spectrometry-based method for detection and differentiation of clinically-relevant KPC variants directly from bacterial cell lysates. The method should be specific for any variant expressed in multiple bacterial species, limit false positive results and be rapid in nature to directly influence clinical outcomes. METHODS: Lysates obtained directly from bacterial colonies were used for intact protein detection using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Bottom-up and top-down proteomic methods were used to characterize the KPC protein targets of interest. Comparisons between KPC-producing and KPC-non-producing isolates from a wide variety of species were also performed. RESULTS: Characterization of the mature KPC protein revealed an unexpected signal peptide cleavage site preceding an AXA signal peptide motif, modifying the molecular weight (MW) of the mature protein. Taking the additional AXA residues into account allowed for direct detection of the intact protein using top-down proteomic methods. Further validation was performed by transforming a KPC-harboring plasmid into a negative control strain, followed by MS detection of the KPC variant from the transformed cell line. Application of this approach to clearly identify clinically-relevant variants among several species is presented for KPC-2, KPC-3, KPC-4 and KPC-5. CONCLUSION: Direct detection of these enzymes contributes to the understanding of occurrence and spread of these antibiotic-resistant organisms. The ability to detect intact KPC variants via a simple LC-MS/MS approach could have a direct and positive impact on clinical therapy, by providing both direction for epidemiological tracking and appropriate therapy.
INTRODUCTION: Carbapenemase-producing organisms (CPOs) are a growing threat to human health. Among the enzymes conferring antibiotic resistance produced by these organisms, Klebsiella pneumoniae carbapenemase (KPC) is considered to be a growing global health threat. Reliable and specific detection of this antibiotic resistance-causing enzyme is critical both for effective therapy and to mitigate further spread. OBJECTIVES: The objective of this study is to develop an intact protein mass spectrometry-based method for detection and differentiation of clinically-relevant KPC variants directly from bacterial cell lysates. The method should be specific for any variant expressed in multiple bacterial species, limit false positive results and be rapid in nature to directly influence clinical outcomes. METHODS: Lysates obtained directly from bacterial colonies were used for intact protein detection using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Bottom-up and top-down proteomic methods were used to characterize the KPC protein targets of interest. Comparisons between KPC-producing and KPC-non-producing isolates from a wide variety of species were also performed. RESULTS: Characterization of the mature KPC protein revealed an unexpected signal peptide cleavage site preceding an AXA signal peptide motif, modifying the molecular weight (MW) of the mature protein. Taking the additional AXA residues into account allowed for direct detection of the intact protein using top-down proteomic methods. Further validation was performed by transforming a KPC-harboring plasmid into a negative control strain, followed by MS detection of the KPC variant from the transformed cell line. Application of this approach to clearly identify clinically-relevant variants among several species is presented for KPC-2, KPC-3, KPC-4 and KPC-5. CONCLUSION: Direct detection of these enzymes contributes to the understanding of occurrence and spread of these antibiotic-resistant organisms. The ability to detect intact KPC variants via a simple LC-MS/MS approach could have a direct and positive impact on clinical therapy, by providing both direction for epidemiological tracking and appropriate therapy.
Authors: Anna F Lau; Honghui Wang; Rebecca A Weingarten; Steven K Drake; Anthony F Suffredini; Mark K Garfield; Yong Chen; Marjan Gucek; Jung-Ho Youn; Frida Stock; Hanna Tso; Jim DeLeo; James J Cimino; Karen M Frank; John P Dekker Journal: J Clin Microbiol Date: 2014-05-21 Impact factor: 5.948
Authors: Leanne B Gasink; Paul H Edelstein; Ebbing Lautenbach; Marie Synnestvedt; Neil O Fishman Journal: Infect Control Hosp Epidemiol Date: 2009-12 Impact factor: 3.254
Authors: C Mirande; I Canard; S Buffet Croix Blanche; J-P Charrier; A van Belkum; M Welker; S Chatellier Journal: Eur J Clin Microbiol Infect Dis Date: 2015-09-04 Impact factor: 3.267
Authors: Cecilia G Carvalhaes; Rodrigo Cayô; Diego M Assis; Evelin R Martins; Luiz Juliano; Maria A Juliano; Ana C Gales Journal: J Clin Microbiol Date: 2012-10-24 Impact factor: 5.948
Authors: Samuel H Payne; Stefano Bonissone; Si Wu; Roslyn N Brown; Dmitry N Ivankov; Dmitrij Frishman; Ljiljana Pasa-Tolić; Richard D Smith; Pavel A Pevzner Journal: MBio Date: 2012-11-20 Impact factor: 7.867
Authors: Miriam Cordovana; Markus Kostrzewa; Jörg Glandorf; Michael Bienia; Simone Ambretti; Arthur B Pranada Journal: Front Microbiol Date: 2018-11-23 Impact factor: 5.640